ICN Pharmaceuticals Buys Drug Cesamet from Eli Lilly
- Share via
Costa Mesa drug maker ICN Pharmaceuticals Inc. said on Friday that it has acquired the drug Cesamet from Eli Lilly and Co. for the Canadian market. Cesamet, the brand name for nabilone, is approved in Canada for the management of severe nausea and vomiting associated with cancer chemotherapy. Cesamet will be marketed and distributed by ICN in Canada. Terms were not disclosed.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
